|
Figure 2 ELISA Validation with SARS-CoV-2 (COVID-19) NSP10 Protein Antibodies: SARS-CoV-2 (COVID-19) NSP10 Antibody, 9179 A direct ELISA was performed using SARS-CoV-2 NSP10 recombinant protein (10-408) as coating antigen and the anti-SARS-CoV-2 (COVID-19) NSP10 antibody as the capture antibody. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:20000 dilution. Detection range is from 1 ng/mL to 3000 ng/mL. |
|
Figure 1 Immunohistochemistry Validation of SARS-CoV-2 (COVID-19) NSP10 in COVID-19 Patient Lung Immunohistochemical analysis of paraffin-embedded COVID-19 patient lung tissue using anti- SARS-CoV-2 (COVID-19) NSP10 antibody (9179, 0.5 &956,g/mL). Tissue was fixed with formaldehyde and blocked with 10% serum for 1 h at RT, antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4&730,C. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin. Strong signal of SARS-COV-2 NSP10 protein was observed in macrophage of COVID-19 patient lung, but not in non-COVID-19 patient lung. |
|
Figure 3 Western Blot Validation with SARS-CoV-2 (COVID-19) NSP10 ProteinLoading: 30 ng per lane of SARS-CoV-2 (COVID-19) NSP10 recombinant protein (10-408).Antibodies: SARS-CoV-2 (COVID-19) NSP10, 9179, 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.Lane 1: 1 &956,g/mL Lane 2: 2 &956,g/mLLane 3: 4 &956,g/mL |